| Active substance |
Gabapentin |
| Also known as |
Neurontin, Gabarone |
| Blood pressure |
Generally has no significant effect on blood pressure |
| Chemical name |
1-(aminomethyl)cyclohexaneacetic acid |
| Classification |
Anticonvulsants |
| Dosage (medical) |
Typically starts at 300 mg on the first day, 300 mg twice on the second day, and 300 mg three times on the third day, up to a maximum of 3600 mg per day, divided into three doses |
| Dosage (sports) |
Not typically used in sports |
| Effects |
Reduces neuropathic pain, controls seizures |
| Formula |
C9H17NO2 |
| Half-life |
5 to 7 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specified |
| Main action |
Anticonvulsant and analgesic |
| Side effects |
Dizziness, fatigue, drowsiness, fluid retention, difficulties with memory |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Gabapentinoid |
| Trade name |
Neurontin, Gralise, others |
| Use in sports |
Not commonly used in sports settings |
| WAREHOUSE |
International Warehouse 1 |
| Water Retention |
Yes, can cause peripheral edema |
| Manufacturer |
Signature |
